Metabolic & Cardiometabolic · Gut & Microbiome
sourdough long fermentation degrades wheat fructans lowering FODMAP load
In plain terms: Does slow-fermented sourdough bread lower the FODMAPs that upset sensitive guts, and is it better tolerated?
Strong support Metabolic & Cardiometabolic 🔬 Includes disconfirming
RefutedContestedStrong support
consensus score 0.91
Yes — long sourdough (and yeast) fermentation measurably degrades wheat fructans/FODMAPs, and small human trials show the resulting bread is better tolerated in wheat-sensitive/IBS eaters, though effect size and clinical magnitude are modest.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
14 support 0 contradict 1 tested null 2 mixed · 17 sources, 14 independent groups
The evidence (17)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Pejcz E et al 2023 · Foods | in-vitro | supports | high | Wheat bread with boosted native sourdough (L. casei, L. plantarum) over up to 72h fermentation; FODMAP content reduced to <0.1 g/100g bread with extended fermentation, alongside increased polyphenols. |
| Habuš M et al 2022 · study_type: in-vitro | in-vitro | supports | moderate | Wheat bran fructan 2.64% dw, amaranth bran 0.96% dw; bioprocessing (yeast alone or combined with inulinase/K. marxianus/L. fermentum/commercial starter LV1, 24h) reduced fructan content up to 93%, with fructose/mannitol kept below the IBS c |
| Shewry 2022 · Food Chemistry | in-vitro | mixed | low | Compositional analysis: both sourdough and yeast fermentation reduced fructans/raffinose, with YEAST having the GREATER effect — degradation is real but not unique to sourdough, human food matrix (analytical). |
| Pejcz E et al 2019 · study_type: in-vitro | in-vitro | supports | moderate | Wheat breads made via yeast-only (I-stage) vs yeast+L. plantarum sourdough (II-stage), 4 fermentation times (60/90/120/150 min); sourdough (II-stage) breads had lower fructan content, decreasing further with longer fermentation time up to 1 |
| Pejcz 2021 · Molecules | in-vitro | supports | moderate | Inoculated lactic-acid sourdough fermentation reduced wheat FODMAP (fructan) content, with longer fermentation time increasing degradation. |
| Laatikainen 2017 · Nutrients | in-vitro | supports | moderate | Randomised double-blind 7-day crossover: greater than 12h-fermented sourdough wheat bread lowered ATIs/FODMAPs and was somewhat better tolerated than yeast bread in wheat-sensitive IBS subjects (pilot, n small, modest symptom difference), human. |
| Calasso M et al 2018 · study_type: RCT | in-vitro | tested-null | moderate | RCT in IBS patients comparing reduced-gluten (fungal protease + sourdough LAB) vs normal-gluten wheat bread/pasta; FODMAPs and amylase/trypsin inhibitors 'also evaluated' as secondary composition metrics; clinical symptom improvement (VAS s |
| Koj K et al 2023 · study_type: in-vitro | in-vitro | supports | moderate | Rye sourdoughs inoculated with S. boulardii, L. plantarum, L. rhamnosus, B. coagulans vs spontaneous fermentation, sampled at 24 and 48h; S. boulardii inoculation gave the greatest reduction in fructans in the resulting rye bread. |
| Menezes 2021 · Int J Food Sci Nutr | in-vitro | supports | moderate | Selected lactic-acid-bacteria type-II sourdough starters markedly reduced bread FODMAPs while maintaining quality. |
| Fraberger 2018 · Nutrients | in-vitro | supports | moderate | 13 sourdough-related yeast strains varied strongly in fructan degradation — effect is strain/process dependent, not guaranteed by sourdough per se, in-vitro/wheat model. |
| Pitsch J et al 2021 · study_type: in-vitro | in-vitro | supports | high | DP2-7 and DP>7 fructooligosaccharide (FOS) content measured in rye and wheat sourdoughs fermented with 4 different microbial strains; FOS reduced to levels below flour controls (-81%/-97% rye, -90%/-76% wheat), fermentation temperature also |
| Sokmen O et al 2025 · Food Science & Nutrition | in-vitro | supports | moderate | Sourdough samples from Marmara Turkey analyzed for FODMAP/fructan; LAB strains isolated from lowest-FODMAP sourdoughs then used to ferment new sourdough; best strains reduced fructan by 48% and FODMAP by approximately 64% vs baseline. |
| Acin Albiac 2020 · Microbial Cell Factories | in-vitro | supports | moderate | Proof-of-concept: baker's yeast/sourdough do lower FODMAPs but residual levels often not low enough for sensitive people without selected fructophilic strains — supports degradation, tempers sufficient-tolerance claim. |
| Cuffe M, et al. 2025 · Lancet Gastroenterol Hepatol | meta-analysis | supports | high | Network meta-analysis confirms low-FODMAP dietary strategies improve IBS symptoms, supporting the tolerability rationale for lower-FODMAP bread. |
| Reidzane S et al 2022 · study_type: in-vitro | in-vitro | mixed | moderate | Glucans, mannans and fructans quantified in hull-less barley and wholegrain wheat breads fermented with spontaneous barley sourdough, germinated barley sourdough, or yeast; wholegrain wheat breads fermented with sourdoughs showed higher fru |
| Di Stasio L et al 2025 · study_type: in-vitro | in-vitro | supports | moderate | Neapolitan pizza dough leavened with sourdough LAB (L. brevis, F. sanfranciscensis, L. pseudomesenteroides) + yeast vs baker's yeast alone, fermentation up to 48h; FODMAPs quantified pre/post in vitro digestion; extended fermentation with L |
| Loponen 2018 · Foods | observational | supports | low | Review: outlines fructan- and mannitol-targeting sourdough metabolism enabling low-FODMAP wholegrain bread; mechanistic/process synthesis, human. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.